TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

AstraZeneca Doubles Down On US Biologics Buildout As Drug Discovery Partnership Grows

Benzinga Logo Benzinga By Vandana Singh
AstraZeneca Doubles Down On US Biologics Buildout As Drug Discovery Partnership Grows

AstraZeneca expands its biologics manufacturing in Maryland with a $2 billion investment and strengthens its drug discovery partnership with Harbour BioMed, focusing on developing next-generation biotherapeutics in immunology and oncology.

Insights
KO   positive

Mentioned as one of top 5 accounts increasing advertising spend with Lamar Advertising


AZN   positive

Investing $2 billion in manufacturing expansion, creating 2,600 jobs, expanding biologics capacity, and extending strategic partnership with Harbour BioMed